FSH floating new offering. What the heck, why not compliment your new purchase and offer stock for NBSC. No it won't add to earnings, but it will give you better margin control over the product lines.
Fisher Scientific Prices Offering of $250 Million of 2.5 Percent Convertible Notes
Business Wire ~ July 1, 2003 ~ 9:27 am EST
HAMPTON, N.H.--(BUSINESS WIRE)--July 1, 2003--Fisher Scientific International Inc. (NYSE: FSH) has priced the private placement of $250 million of 2.5 percent convertible senior unsecured notes due 2023. The notes will be convertible into Fisher common stock at a conversion price of $47.46 per share, subject to adjustment in certain circumstances. The initial conversion price represents a 36 percent premium over the closing bid price of Fisher common stock on June 30, 2003, which was $34.90 per share. The company has also granted the initial purchasers of the notes a 30-day option to purchase up to an additional $50 million in principal amount of the notes.
The private placement is expected to close on July 7, 2003, subject to customary closing conditions.
The notes will be offered in the United States to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933. The notes have not been registered under the Securities Act and may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or a solicitation of any offer to buy such notes and is issued pursuant to Rule 135c under the Securities Act.
About Fisher Scientific International Inc.
As the world leader in serving science, Fisher Scientific International Inc. ( NYSE: FSH) offers more than 600,000 products and services to more than 350,000 customers located in approximately 145 countries. As a result of its broad product offering, electronic-commerce capabilities and integrated global logistics network, Fisher serves as a one-stop source of products, services and global solutions for its customers. The company primarily serves the scientific- research, clinical-laboratory and safety markets. Additional information about Fisher is available on the company's Web site at www.fisherscientific.com.
This announcement includes forward-looking statements. Fisher Scientific has based these forward-looking statements on its current expectations and projections about future events. Although Fisher Scientific believes that its assumptions made in connection with the forward-looking statements are reasonable, no assurances can be given that its assumptions and expectations will prove to have been correct. These forward-looking statements are subject to various risks, uncertainties and assumptions. Fisher Scientific undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this announcement might not occur |
